PMID: 6409291Jul 30, 1983Paper

Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction

British Medical Journal
L E DalyN Hickey

Abstract

Subjects who stop smoking cigarettes after myocardial infarction have an improved rate of survival compared with those who continue, but to date it was not known whether the benefit persisted for more than six years. A total of 498 men aged under 60 years who had survived a first episode of unstable angina or myocardial infarction by two years were followed up by life table methods for a further 13 years. Mortality in those who continued to smoke was significantly higher (82.1%) than in those who stopped smoking (36.9%). These differences increased with time. Mortality in those who were non-smokers initially and who continued not to smoke was intermediate (62.1%). The adverse effect of continued smoking was most pronounced in those with unstable angina. Continuing to smoke increased the rate of sudden death to a greater degree in those with less severe initial attacks, while the effect of smoking on fatal reinfarctions was most apparent in those with a more complicated presentation. These findings suggest that stopping cigarette smoking is the most effective single action in the management of patients with coronary heart disease.

References

Feb 22, 1975·Lancet·C WilhelmssonL Wilhelmsen
Feb 1, 1976·American Journal of Epidemiology·O Miettinen
Dec 1, 1981·British Journal of Addiction·G RonanR Mulcahy
Dec 1, 1958·Journal of Chronic Diseases·S J CUTLER, F EDERER

❮ Previous
Next ❯

Citations

Jul 11, 1991·Journal of General Internal Medicine·N A RigottiG E Thibault
May 1, 2002·Environmental Health and Preventive Medicine·Atsuhiko OtaNorito Kawakami
Jun 9, 2009·Journal of Behavioral Medicine·Shannon Gravely-WitteSherry L Grace
Nov 1, 1986·Progress in Cardiovascular Diseases·N K Wenger
Nov 15, 1993·Journal of the American College of Cardiology·H M KrumholzM C Weinstein
Jan 31, 2004·American Journal of Preventive Medicine·David W BrownRoss J Simpson
Jun 26, 1999·Atherosclerosis·D Wood
Aug 16, 2003·Progress in Cardiovascular Diseases·David M Burns
Aug 16, 2003·Progress in Cardiovascular Diseases·Neal L Benowitz
Jan 1, 1985·Journal belge de radiologie·P FarrB Litvin
Feb 1, 1996·Cardiology Clinics·R F DeBusk
Jan 10, 1998·Patient Education and Counseling·K McKenna, H Higgins
Mar 25, 2008·Journal of Cardiopulmonary Rehabilitation and Prevention·Julie RedfernSaul B Freedman
Oct 5, 1985·British Medical Journal·L E DalyR Mulcahy
Dec 16, 1989·BMJ : British Medical Journal·H J Dargie
Jun 6, 1998·BMJ : British Medical Journal·N C CampbellJ M Rawles
Jun 6, 1998·BMJ : British Medical Journal·N C CampbellJ L Squair
Dec 4, 2003·BMJ : British Medical Journal·Petter Quist-Paulsen, Frode Gallefoss
Dec 1, 1995·Journal of Epidemiology and Community Health·D C GreenwoodR J Madeley
Jan 1, 1994·Lancet·G C Leng
Feb 2, 2006·Scandinavian Cardiovascular Journal : SCJ·Petter Quist-PaulsenFrode Gallefoss
May 1, 1990·Mayo Clinic Proceedings·R W SquiresC J Lavie
Apr 16, 2008·Journal of Clinical Epidemiology·Shannon Gravely-WitteSherry L Grace
Sep 12, 2007·Heart & Lung : the Journal of Critical Care·Min SohnErika Sivarajan Froelicher
Jan 1, 2008·The Clinical Respiratory Journal·Petter Quist-Paulsen
Feb 1, 1993·International Journal of Cardiology·A Leone
Feb 1, 1985·Clinical Cardiology·R M Conroy, R Mulcahy
Jan 23, 1999·Heart & Lung : the Journal of Critical Care·J L JohnsonC Miller
Feb 1, 1996·The American Journal of Cardiology·D G Meyers
Jan 1, 1992·The American Journal of Medicine·T A Manolio, C D Furberg
Sep 27, 2003·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·K CassarJ Brittenden

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.